Teva Share Price

Teva Share Price

NYSE: TEVA | Large Cap | Healthcare
$42.16
-$0.46 (-1.09%) Last updated on 19 Nov, 2026 | 01:27 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Teva Stock Performance

Open
$42.78
Prev. Close
$42.62
Circuit Range
N/A
Day Range
$42.05 - $43.03
Year Range
$24.01 - $44.53
Volume
3,79,914
Average Traded
$42.33

Teva Share Price Today

As of 19 November 2026, Teva Pharmaceutical Industries Limited's share price is $42.16. The stock opened at $42.78, compared to its previous close of $42.62. During today's trading session, Teva Pharmaceutical Industries Limited's share price traded between $42.05 and $43.03, with an average price of $42.54. Over the past 52 weeks, the stock has recorded a high of $44.53 and a low of $24.01. In terms of performance, Teva Pharmaceutical Industries Limited's share price has risen by 19.59% over the last six months and is up 56.89% on a year-on-year basis.

Teva Share Price Chart

Line chart of the Teva price trend over the selected period. The price fell overall, ranging from 42.05 to 43.00, ending at 42.16.
$42.05$43.03
L
Show Current Price
H

Teva Stock Fundamentals & Key Indicators

Market Cap
$48.27B
PE Ratio (TTM)
97.89
Dividend Yield
0.00%
EPS (TTM)
$0.44
Revenue (TTM)
$17.26B
Return On Equity (TTM)
6.37%
Profit Margin
8.17%
Debt to Equity
2.10
Quarterly Earnings Growth YoY
-51.25%

Teva Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$4711.00$3982.00$4142.00$4395.00
Net Profit$480.00$370.00-$576.00$234.00
Net Profit Margin10.19%9.29%-13.91%5.32%
Income ChangeN/A-22.92%-255.68%140.63%

Teva Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$14.93$15.85$16.54$17.26
Net Profit-$2.45-$0.56-$1.64$1.41
Net Profit Margin-16.41%-3.53%-9.92%8.17%
Income ChangeN/A77.14%-192.86%185.98%

Teva Balance Sheet

All figures in USD Billion

Particulars2025202420232022
Non Current Assets26.826.7730.9931.96
Current Assets13.9512.5512.4912.05
Total Assets40.7539.3343.4844.01
Non Current Liabilities19.7321.5123.1123.95
Current Liabilities13.112.112.2511.47
Total Liabilities32.8333.6135.3535.41
Shareholders' Equity7.915.388.138.6

Teva Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating1,649.01,247.01,368.01,590.0
Investing737.0792.0968.0656.0
Financing-2,151.0-1,791.0-1,913.0-1,487.0

About Teva

Teva Pharmaceutical, based in Israel, is the world's leading generic drug manufacturer. Teva derives half its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in two main therapeutic areas: neurology and immunology. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

Teva Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$41.09
$42.13
+0.23%
Oct 2026
$39.48
$42.03
+6.03%
Sep 2026
$36.39
$39.64
+5.40%
Aug 2026
$34.85
$37.61
+7.46%
Jul 2026
$33.94
$35.00
+3.31%
Jun 2026
$34.70
$33.88
-3.89%
May 2026
$35.13
$35.25
+0.48%
Apr 2026
$30.49
$35.08
+16.51%
Mar 2026
$33.86
$30.11
-11.01%
Feb 2026
$34.51
$33.84
-0.78%
Jan 2026
$31.28
$34.10
+9.26%
Dec 2025
$26.61
$31.21
+16.15%

Teva Share Price FAQs